Cytek Biosciences Valuation
| CTKB Stock | USD 5.20 0.07 1.33% |
At this time, the firm appears to be fairly valued. Cytek Biosciences shows a prevailing Real Value of $5.21 per share. The current price of the firm is $5.2. Our model approximates the value of Cytek Biosciences from analyzing the firm fundamentals such as Profit Margin of (0.07) %, return on equity of -0.0336, and Current Valuation of 436.94 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Cytek Biosciences' price fluctuation is relatively risky at this time. Calculation of the real value of Cytek Biosciences is based on 3 months time horizon. Increasing Cytek Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cytek Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cytek Stock. However, Cytek Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.2 | Real 5.21 | Hype 5.14 | Naive 4.53 |
The real value of Cytek Stock, also known as its intrinsic value, is the underlying worth of Cytek Biosciences Company, which is reflected in its stock price. It is based on Cytek Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cytek Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cytek Biosciences helps investors to forecast how Cytek stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cytek Biosciences more accurately as focusing exclusively on Cytek Biosciences' fundamentals will not take into account other important factors: About Cytek Biosciences Valuation
The stock valuation mechanism determines Cytek Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cytek Biosciences. We calculate exposure to Cytek Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cytek Biosciences's related companies.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Cytek Biosciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 555 people.
Cytek Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 130.6 M | |
| Quarterly Earnings Growth Y O Y | 0.735 | |
| Forward Price Earnings | 370.3704 |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |